abstract |
The present invention relates to azolopyrimidinone compounds useful for treating cell proliferative disorders, treating disorders associated with KSP kinesin activity, and inhibiting KSP kinesin. The invention also relates to compositions comprising these compounds and methods for their use in treating cancer in mammals. |